Sherrill, Gary C.
Esckilsen, Scott
Hudson, Joshua
Kochar, Bharati
Herfarth, Hans H.
Barnes, Edward L. http://orcid.org/0000-0001-9894-8796
Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (K23DK127157-01)
Article History
Received: 23 September 2021
Accepted: 7 February 2022
First Online: 5 March 2022
Declarations
:
: ELB has served as a consultant for AbbVie, Pfizer, and Target RWE. BK has served as a consultant for Pfizer. HHH has served as a consultant for Alivio, AMAG, Finch, Gilead, Lycera, Merck, Otsuka, Pfizer, PureTech, Seres and research support from Pfizer and Artizan Biosciences. GCS, JH, and SE have no relevant disclosures.